Vote Scores
Filings read through

United Therapeutics Corporation: how funds voted at the meeting of 26 Jun 2024

Ticker
UTHR
Meeting
Season
year to 30 June 2024
Filers reporting
725
Ballot items
4

725 filers on Form N-PX reported votes at the United Therapeutics Corporation meeting of 26 Jun 2024. The records fall into 4 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2024. The latest season on file is the year to 30 June 2026. The page of United Therapeutics Corporation has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2024. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    12 nominees. 95.0% of the reported votes are for. 49 filers withheld from or voted against at least one nominee.

    6,866 vote records from 235 filers. 9 of the 234 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 47 fund families
    • For 46
    • Against 1
    • Against management 1
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    1,194 vote records from 712 filers. 56 of the 698 filers that marked the item voted against management. 14 filers gave no management mark.

    0 filers reported share counts too large for the holding. The site publishes no share split for this item. The rule

    • Positions of 50 fund families
    • For 50
  3. Item 3: Audit-related items (auditor ratification)

    573 vote records from 234 filers. 8 of the 233 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 47 fund families
    • For 46
    • Against 1
    • Against management 1
  4. Item 4: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    596 vote records from 239 filers. 29 of the 238 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 47 fund families
    • For 41
    • Against 6
    • Against management 6

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at United Therapeutics Corporation, meeting of 26 Jun 2024Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Auditor
AllianceBernsteinForFor
AllspringForFor
American CenturyForFor
BairdForNo report
BlackRock and iSharesForFor
BNY MellonForFor
Brighthouse FundsForFor
Charles SchwabForFor
Columbia ThreadneedleForFor
DimensionalForFor
DWSForNo report
EquitableForFor
Federated HermesForFor
FidelityForFor
First TrustForFor
Franklin TempletonForFor
Global XForFor
Goldman SachsForFor
Guggenheim and RydexForFor
Harbor FundsForFor
Hartford FundsForFor
InvescoForFor
J.P. MorganForFor
Jackson National fundsForFor
Janus HendersonForFor
John Hancock and ManulifeForFor
Lincoln FinancialForFor
Macquarie and Delaware FundsForFor
MassMutualForFor
Morgan Stanley, Eaton Vance and CalvertForFor
NationwideForFor
Natixis and Loomis SaylesForFor
Neuberger BermanForNo report
Northern Trust and FlexSharesForFor
Nuveen and TIAAForFor
Pacific Life fundsForFor
PGIM and PrudentialForFor
PIMCOForAgainst, against management
PrincipalForFor
ProShares and ProFundsForFor
Russell InvestmentsForFor
SEIForFor
State Street and SPDRForFor
T. Rowe PriceForFor
ThriventForFor
TransamericaForFor
VanguardForFor
Victory CapitalForFor
VoyaForFor
WisdomTreeForFor

Questions

How many filers reported votes at the United Therapeutics Corporation meeting?
725 Form N-PX filers reported votes at the meeting of 26 Jun 2024. On say-on-pay, 56 of 698 filers that marked the item voted against management (8.0%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. United Therapeutics Corporation reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list United Therapeutics Corporation with a meeting date within three days of 26 Jun 2024. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .